At Biogen Idec, our mission is to discover, develop and deliver to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. We pursue that mission any way we can. So, while we are proud of our ability to develop treatments through our own internal R&D, we are equally committed to alliances and partnerships.
Our approach to partnerships reflects the same dedication to innovation seen everywhere in the company. We are flexible enough to structure a partnership in any way that makes sense for both companies. We offer the ideal blend of large (broad resources) and small (personal attention). And every partnership is built on a foundation of mutual respect and aligned interests.
We work with companies at all stages in the development process, from proof-of-concept to Phase 3 testing and beyond.
We welcome the opportunity to discuss a partnership arrangement or alliance with any appropriate organization.
Alliances that work
Many of our products, both current and in the pipeline, are a result of alliances and collaborations. We have collaborated more than once with many of our partners, proof of the success of these relationships. Among our partners:
Eisai Co., Inc.
Neurimmune Therapies AG
Swedish Orphan Biovitrium AB (publ) (Sobi)
UCB S.A., Ltd.